GRETCHEN GARLAND: Open Payments
NPI 1215552567 · OSWEGO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 31 payments from 6 companies in 2025. Trend: 2023 $662 · 2024 $212 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 24 | $249 |
| Neurocrine BioSciences, Inc. | 1 | $95 |
| ABBVIE INC. | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Alkermes, Inc. | 1 | $14 |
Products named: COBENFY, INGREZZA, VRAYLAR, CAPLYTA, REXULTI, ARISTADA.
Industry payments across NY — which companies pay providers there.
